Prior studies indicate that the editing activity of ADAR1 and ADAR2 can be regulated by ADAR3, the deaminase-deficient ADAR family member, in vitro and for at least one transcript in a brain cancer cell line (12, 25). Here, ADARB2 is linked to brain cancer.